MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 12, 2006; DOI: 10.1124/mol.105.019844


0026-895X/06/6905-1518-1526$20.00
Mol Pharmacol 69:1518-1526, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.105.019844v1
mol.105.019844v2
69/5/1518    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushwaha, N.
Right arrow Articles by Albert, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushwaha, N.
Right arrow Articles by Albert, P. R.

Molecular Determinants in the Second Intracellular Loop of the 5-Hydroxytryptamine-1A Receptor for G-Protein CouplingFormula

Neena Kushwaha, Shannon C. Harwood, Ariel M. Wilson, Miles Berger, Laurence H. Tecott, Bryan L. Roth, and Paul R. Albert

Ottawa Health Research Institute (Neuroscience) and Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada (N.K., S.C.H., A.M.W., P.R.A.); Department of Psychiatry, Center for Neurobiology and Psychiatry, Institute for Neurodegenerative Diseases, University of California, San Francisco School of Medicine, San Francisco, California (M.B., L.H.T.); and Department of Biochemistry, Case Western Reserve University Medical School, Cleveland, Ohio (B.R.L.)

This study provides the first comprehensive evidence that the second intracellular loop C-terminal domain (Ci2) is critical for receptor-G protein coupling to multiple responses. Although Ci2 is weakly conserved, its role in 5-hydroxytryptamine-1A (5-HT1A) receptor function was suggested by the selective loss of Gbeta{gamma}-mediated signaling in the T149A-5-HT1A receptor mutant. More than 60 point mutant 5-HT1A receptors in the {alpha}-helical Ci2 sequence (143DYVNKRTPRR152) were generated. Most mutants retained agonist binding and were tested for Gbeta{gamma} signaling to adenylyl cyclase II or phospholipase C and G{alpha}i coupling to detect constitutive and agonist-induced Gi/Go coupling. Remarkably, most point mutations markedly attenuated 5-HT1A signaling, indicating that the entire Ci2 domain is critical for receptor G-protein coupling. Six signaling phenotypes were observed: wild-type-like, G{alpha}i-coupled/weak Gbeta{gamma}-coupled, Gbeta{gamma}-uncoupled, Gbeta{gamma}-selective coupled, uncoupled, and inverse coupling. Our data elucidate specific roles of Ci2 residues consistent with predictions based on rhodopsin crystal structure. The absolute coupling requirement for lysine, arginine, and proline residues is consistent with a predicted amphipathic {alpha}-helical Ci2 domain that is kinked at Pro150. Polar residues (Thr149, Asn146) located in the externally oriented positively charged face were required for Gbeta{gamma} but not G{alpha}i coupling, suggesting a direct interface with Gbeta{gamma} subunits. The hydrophobic face includes the critical Tyr144 that directs the specificity of coupling to both Gbeta{gamma} and G{alpha}i pathways. The key coupling residues Tyr144/Lys147 (Ci2) are predicted to orient internally, forming hydrogen and ionic bonds with Asp133/Arg134 (Ni2 DRY motif) and Glu340 (Ci3) to stabilize the Gprotein coupling domain. Thus, the 5-HT1A receptor Ci2 domain determines Gbeta{gamma} specificity and stabilizes G{alpha}i-mediated signaling.


Received October 12, 2005; accepted January 12, 2006

Address correspondence to: Dr. Paul R. Albert, Ottawa Health Research Institute (Neurosciences), 451 Smyth Road, Ottawa, Ontario, Canada, K1H 8M5. E-mail: palbert{at}uottawa.ca




This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. Carrel, J. Masson, S. Al Awabdh, C. B. Capra, Z. Lenkei, M. Hamon, M. B. Emerit, and M. Darmon
Targeting of the 5-HT1A Serotonin Receptor to Neuronal Dendrites Is Mediated by Yif1B
J. Neurosci., August 6, 2008; 28(32): 8063 - 8073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Xu, B. Yao, X. Fan, M. M. Langworthy, M.-Z. Zhang, and R. C. Harris
Characterization of a putative intrarenal serotonergic system
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1468 - F1475.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rogaeva, X.-M. Ou, H. Jafar-Nejad, S. Lemonde, and P. R. Albert
Differential Repression by Freud-1/CC2D1A at a Polymorphic Site in the Dopamine-D2 Receptor Gene
J. Biol. Chem., July 20, 2007; 282(29): 20897 - 20905.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics